FRI 23 OCTEvening3:27 AM

Back to the brief

HLTHBBC News

First personalised cancer vaccine cuts risk of disease returning in major trial

Photo: BBC

A new personalised cancer vaccine given alongside a widely used immunotherapy drug has cut the risk of patients dying or their skin cancer returning by 42% in a major clinical trial.

The researchers involved say the results could mark a turning point in cancer treatment, bringing personalised medicine a step closer.

The trial also found that the new drug combination reduced the risk of melanoma, a type of skin cancer, spreading by 38% over two years compared to immunotherapy alone.

Read the original report

Opens BBC News in a new tab

HLTHThe Guardian

Flu cases rise on west coast earlier than usual as US health experts encourage vaccine

California flu test rate at 9.65%, higher than normal 1% rate for early October, amid mutation of H1N1 influenza A strain Flu cases on the west coast are on the rise months earlier than normal, prompting US health experts to stress the importance of the annual vaccine. Flu activity typically ramps up in December, hitting its peak in February. But this season has kicked into action earlier this year, with higher positive cases than normal recorded.

HLTHThe Guardian

RFK Jr’s ‘deities of vaccine research’ raided by police in Guinea-Bissau

Police seize doses of hepatitis B vaccine from people at center of dispute over research on African newborns Controversial vaccine researchers who have been praised by Robert F Kennedy Jr, the US Department of Health and Human Services (HHS) secretary, had their offices in Guinea-Bissau raided by judicial police, who seized doses of hepatitis B vaccines, officials said on Facebook. The researchers have been at the heart of an ongoing dispute over research on African newborns, supported by $1.6m from the US Centers for Disease Control and Prevention…